title: Treatment results in aplastic anemia trials need to be analyzed separately for pediatric and adult populations.
authors.forename: V
authors.initials: V
authors.lastname: Reddy
authors.forename: S
authors.initials: S
authors.lastname: Khan
authors.forename: J R
authors.initials: JR
authors.lastname: Wingard
authors.forename: P
authors.initials: P
authors.lastname: Mehta
mesh_terms: D000328:Adult; D000367:Age Factors; D000741:Anemia, Aplastic / Q000188:drug therapy* / Q000503:physiopathology; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine